Biocryst Pharmaceuticals Inc layoffs
Yes. Biocryst Pharmaceuticals Inc has filed 2 SEC 8-Ks with Item 2.05 (exit or disposal costs) since 2023. The most recent, on Aug 4, 2026, disclosed a workforce reduction.
Check BCRX layoff riskSEC filings since 2023
- Aug 42026
Biocryst Pharmaceuticals discloses a workforce reduction
Biocryst Pharmaceuticals Inc (BCRX) · filed 14 weeks agoOn June 29, 2026, the Company announced its plan to discontinue the Company’s internal discovery programs and close its Discovery Center of Excellence facility in Birmingham, Alabama (the "Plan") as part of the Company’s ongoing strategic evolution to strengthen its rare disease pipeline.
- Jun 292026
Biocryst Pharmaceuticals discloses a workforce reduction
Biocryst Pharmaceuticals Inc (BCRX) · filed 19 weeks agoOn June 25, 2026, the Board of Directors of BioCryst Pharmaceuticals, Inc. (the "Company") approved a plan to discontinue the Company’s internal discovery programs and close its Discovery Center of Excellence facility in Birmingham, Alabama (the "Plan").
Get this data via API
Pull layoff filings, risk scores, and WARN notices into your own product. Starts at $49/mo.